Zydus Lifesciences Limited

Symbol: ZYDUSLIFE.NS

NSE

981.35

INR

Market price today

  • 32.9550

    P/E Ratio

  • -2.1529

    PEG Ratio

  • 987.46B

    MRK Cap

  • 0.01%

    DIV Yield

Zydus Lifesciences Limited (ZYDUSLIFE-NS) Financial Statements

On the chart you can see the default numbers in dynamics for Zydus Lifesciences Limited (ZYDUSLIFE.NS). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Zydus Lifesciences Limited, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006200520042003

balance-sheet.row.cash-and-short-term-investments

0142043504811272
13396
10004
17921
16049
9284
7911
6132
6771
4696
2952
2507
2517
926
990
438
612
442

balance-sheet.row.short-term-investments

09326284704620
4943
5797
4772
614
2331
1212
644
933
30
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

0442545032443498
45779
47563
36290
24303
20503
18939
14641
12876
8863
7652
4668
4845
3555
2784
1990
1235
2012

balance-sheet.row.inventory

0341333719432362
27890
26880
23853
18037
14512
15357
13675
12136
10905
8119
7504
5853
4593
3717
2338
2108
1700

balance-sheet.row.other-current-assets

075734828
89
534
4233
1834
77
60
89
134
3167
4106
3070
2834
2149
2380
1725
1115
868

balance-sheet.row.total-current-assets

010016412261487160
87154
84981
82297
60223
44376
42267
34537
31917
27631
22829
17749
16049
11223
9871
6491
5070
5022

balance-sheet.row.property-plant-equipment-net

0682676422663332
61937
59431
53429
48337
36490
32154
30491
27558
22018
15472
12598
10605
9357
7581
6231
5585
5050

balance-sheet.row.goodwill

0480445364653465
53915
52890
13853
11494
8937
8950
8989
9232
0
0
4796
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0109051127212363
13868
17688
12816
13153
2469
397
673
822
11300
0
933
6041
4315
1861
1721
1944
2191

balance-sheet.row.goodwill-and-intangible-assets

0589496491865828
67783
70578
26669
24647
11406
9347
9662
10054
11300
5654
5729
6041
4315
1861
1721
1944
2191

balance-sheet.row.long-term-investments

0927393486312
5522
4436
9290
8664
-1999
-880
-422
-721
182
0
0
249
254
261
714
467
479

balance-sheet.row.tax-assets

0126241095810744
14374
9703
9246
5170
0
0
0
0
30
0
0
350
221
197
196
159
179

balance-sheet.row.other-non-current-assets

0828758905471
96
5702
-278
5166
9890
7583
5597
4914
2661
1717
1308
790
583
602
1091
844
981

balance-sheet.row.total-non-current-assets

0157400155340151687
149712
149850
98356
91984
55787
48204
45328
41805
36161
22843
19635
17786
14476
10241
9239
8532
8401

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0257564277954238847
236866
234831
180653
152207
100163
90471
79865
73722
63792
45672
37384
33835
25699
20112
15730
13602
13423

balance-sheet.row.account-payables

0212502137822059
20310
19226
18884
16736
13449
10909
9108
6568
5455
8306
6146
5255
3641
3844
1973
1630
1549

balance-sheet.row.short-term-debt

0117513842739830
47847
39497
28516
27388
15456
15009
13382
14918
6871
55
0
0
0
0
0
0
0

balance-sheet.row.tax-payables

01568418884
291
537
520
116
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

019837826246
32291
39497
25551
24684
8964
11504
13622
14260
13223
10973
10905
12674
8377
4535
4432
3833
4376

Deferred Revenue Non Current

0295287227
76
67
65
65
59
55
54
50
756
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

02705345241
164
203
211
8934
5166
6731
5650
5218
9236
2827
2515
1660
1410
1602
1036
1036
983

balance-sheet.row.total-non-current-liabilities

05374902210938
37068
44614
31470
27988
11219
13617
15892
16380
15590
12100
12046
14340
9832
5869
5725
5002
5527

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0317249241
274
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0606818741689551
119762
118039
91298
81046
45290
46266
44032
43084
37152
23288
20707
21255
14883
11315
8734
7668
8059

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0101210241024
1024
1024
1024
1024
1024
1024
1024
1024
1024
1024
682
682
628
628
314
314
314

balance-sheet.row.retained-earnings

0171898154958113842
86124
82643
67707
50463
34660
23381
15283
11263
0
0
0
1704
1092
223
1593
933
720

balance-sheet.row.accumulated-other-comprehensive-income-loss

02481201413057
14609
18196
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0200020002000
2000
2000
18714
18113
17835
18111
18083
17158
24712
20691
15603
9966
8902
7804
5082
4687
4330

balance-sheet.row.total-stockholders-equity

0175158169996129923
103757
103863
87445
69600
53519
42516
34390
29445
25736
21715
16285
12352
10622
8655
6989
5934
5364

balance-sheet.row.total-liabilities-and-stockholders-equity

0257564277954238847
236866
234831
180653
152207
100163
90471
79865
73722
63792
45672
37384
33835
25699
20112
15730
13602
13423

balance-sheet.row.minority-interest

0217252054219373
13347
12929
1910
1561
1354
1689
1443
1193
904
669
392
228
194
142
7
0
0

balance-sheet.row.total-equity

0196883190538149296
117104
116792
89355
71161
54873
44205
35833
30638
26640
22384
16677
12580
10816
8797
6996
5934
5364

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

01425396876867
14710
14246
14062
9278
332
332
222
212
212
849
746
249
254
261
714
467
479

balance-sheet.row.total-debt

0119494220946076
80138
78994
54067
52072
24420
26513
27004
29178
20094
11028
10905
12674
8377
4535
4432
3833
4376

balance-sheet.row.net-debt

070713563139424
71685
74787
40918
36637
17467
19814
21516
23340
15428
8076
8398
10157
7451
3545
3994
3221
3934

Cash Flow Statement

The financial landscape of Zydus Lifesciences Limited has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006200520042003

cash-flows.row.net-income

0258275232322848
14954
23821
23120
16119
21237
14455
9422
8087
7942
8425
6039
3031
2576
2338
1524
1215
1331

cash-flows.row.depreciation-and-amortization

0722773617248
6965
5986
5405
3750
3022
2873
2012
1847
1579
1269
1339
1118
969
823
779
716
712

cash-flows.row.deferred-income-tax

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-2358-35151868
1294
6378
-13839
-3728
2656
-3770
-359
-1996
-4452
-2054
-1236
-1210
-2115
-628
-1345
164
82

cash-flows.row.account-receivables

0-8485-18174313
5636
-6428
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

04407-5255-4797
-1010
-1004
-5924
-4666
845
-1682
-1540
-1230
-2786
-615
-1492
-1283
-833
-1421
-254
-453
245

cash-flows.row.account-payables

0-1708-12031709
564
-2259
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

034284760643
-3896
16069
-7915
938
1811
-2088
1181
-766
-1666
-1439
256
73
-1282
793
-1091
617
-163

cash-flows.row.other-non-cash-items

0-3808-35128966
1841
-7362
-5493
-2646
-6977
-3622
-2205
-2029
-50
-944
182
-753
423
-12
153
196
214

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-10309-12026-8540
-9041
-10574
-10493
-29781
-9718
-5124
-4682
-7243
-12444
-4894
-3321
-4069
-5035
-2355
-1223
-1248
-1040

cash-flows.row.acquisitions-net

0114620711035
1565
-48677
0
0
0
0
0
0
0
0
280
196
0
0
0
147
0

cash-flows.row.purchases-of-investments

0-2606-7837-400
-1850
-48813
0
0
-1
-115
-10
-903
-1665
-5
-842
-5
0
0
-247
-5
-556

cash-flows.row.sales-maturities-of-investments

023356751101
285
1354
116
53
0
5
0
23
1690
0
300
10
7
201
0
33
0

cash-flows.row.other-investing-activites

012528585579
-1082
49323
640
625
680
587
470
528
516
369
-232
-227
110
480
69
1
422

cash-flows.row.net-cash-used-for-investing-activites

01171211544-7225
-10123
-57387
-9737
-29103
-9039
-4647
-4222
-7595
-11903
-4530
-3815
-4095
-4918
-1674
-1401
-1072
-1174

cash-flows.row.debt-repayment

0-9960-14208-25683
-7855
-1704
-2646
-6447
-4684
-8998
-4209
-2941
-2902
-601
-1768
0
0
0
0
-543
-526

cash-flows.row.common-stock-issued

01859209866
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0-86320-8337
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-2671-3722-15
-7166
-3583
0
-3271
-5789
-1839
-1533
-1523
-1266
-1012
-154
-709
-841
-398
-481
-506
-310

cash-flows.row.other-financing-activites

0-413339247-1320
4079
24133
3161
32876
946
7326
455
7322
12766
-108
-597
4205
3842
103
597
0
0

cash-flows.row.net-cash-used-provided-by-financing-activities

0-44004-8683-25489
-10942
18846
515
23158
-9527
-3511
-5287
2858
8598
-1721
-2519
3496
3001
-295
116
-1049
-836

cash-flows.row.effect-of-forex-changes-on-cash

06686-42
79
1609
0
6
0
0
0
0
0
0
0
4
0
0
0
0
10

cash-flows.row.net-change-in-cash

0-533823729-905
3989
-7105
-29
7556
1372
1778
-639
1172
1714
445
-10
1591
-64
552
-174
170
339

cash-flows.row.cash-at-end-of-period

057313460110872
11777
8792
15897
15926
9276
7904
6126
5838
4666
2952
2507
2517
926
990
438
612
442

cash-flows.row.cash-at-beginning-of-period

0110691087211777
7788
15897
15926
8370
7904
6126
6765
4666
2952
2507
2517
926
990
438
612
442
103

cash-flows.row.operating-cash-flow

0268882104132930
25054
28823
9193
13495
19938
9936
8870
5909
5019
6696
6324
2186
1853
2521
1111
2291
2339

cash-flows.row.capital-expenditure

0-10309-12026-8540
-9041
-10574
-10493
-29781
-9718
-5124
-4682
-7243
-12444
-4894
-3321
-4069
-5035
-2355
-1223
-1248
-1040

cash-flows.row.free-cash-flow

016579901524390
16013
18249
-1300
-16286
10220
4812
4188
-1334
-7425
1802
3003
-1883
-3182
166
-112
1043
1299

Income Statement Row

Zydus Lifesciences Limited's revenue saw a change of NaN% compared with the previous period. The gross profit of ZYDUSLIFE.NS is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006200520042003

income-statement-row.row.total-revenue

0168778148276148215
138121
127484
115993
94295
98376
86513
72240
63577
50900
44647
36868
28624
22660
17855
14453
12430
11962

income-statement-row.row.cost-of-revenue

0631015818954800
51494
49499
43429
36362
34598
33097
28211
24083
20555
14754
11784
9566
7903
6372
5688
4840
5007

income-statement-row.row.gross-profit

01056779008793415
86627
77985
72564
57933
63778
53416
44029
39494
30345
29893
25084
19058
14757
11483
8765
7590
6955

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

018663151
84
81
46
80
131
92
28
24
24316
-517
-46
5279
4294
3239
2123
2479
2336

income-statement-row.row.operating-expenses

0771496532067152
66059
54756
49562
42573
42931
38527
33924
29981
24316
20769
18178
13914
11119
8521
5667
5712
5104

income-statement-row.row.cost-and-expenses

0140250123509121952
117553
104255
92991
78935
77529
71624
62135
54064
44871
35523
29962
23480
19022
14893
11355
10552
10111

income-statement-row.row.interest-income

0757688503
325
530
494
573
601
387
343
267
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

0129911441604
3236
1905
1047
568
410
555
1101
1167
0
0
0
1205
335
223
251
245
210

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-16854102-2890
-5776
364
306
759
390
-434
-683
-1426
1913
-699
-867
-1446
-404
-223
-1330
-507
-336

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

018663151
84
81
46
80
131
92
28
24
24316
-517
-46
5279
4294
3239
2123
2479
2336

income-statement-row.row.total-operating-expenses

0-16854102-2890
-5776
364
306
759
390
-434
-683
-1426
1913
-699
-867
-1446
-404
-223
-1330
-507
-336

income-statement-row.row.interest-expense

0129911441604
3236
1905
1047
568
410
555
1101
1167
0
0
0
1205
335
223
251
245
210

income-statement-row.row.depreciation-and-amortization

0722773617248
6965
5986
5405
3750
3022
2873
2012
1847
1579
1269
1339
1118
969
823
779
716
712

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0285282474127356
21018
23926
23002
15360
20847
14889
10105
9513
6029
9124
6906
5144
3638
2962
3098
1878
1851

income-statement-row.row.income-before-tax

0258972838122848
14954
23821
23308
16119
21237
14455
9422
8087
7942
8425
6039
3698
3234
2739
1768
1371
1515

income-statement-row.row.income-tax-expense

0587851171472
3198
5303
5644
1289
5711
2594
1060
1188
1130
1064
741
666
613
324
243
192
213

income-statement-row.row.net-income

0196034487321336
11766
18488
17758
14877
15226
11485
8036
6535
6526
7110
5051
3031
2576
2338
1524
1215
1331

Frequently Asked Question

What is Zydus Lifesciences Limited (ZYDUSLIFE.NS) total assets?

Zydus Lifesciences Limited (ZYDUSLIFE.NS) total assets is 257564000000.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.659.

What is company free cash flow?

The free cash flow is 14.570.

What is enterprise net profit margin?

The net profit margin is 0.161.

What is firm total revenue?

The total revenue is 0.239.

What is Zydus Lifesciences Limited (ZYDUSLIFE.NS) net profit (net income)?

The net profit (net income) is 19603000000.000.

What is firm total debt?

The total debt is 11949000000.000.

What is operating expences number?

The operating expences are 77149000000.000.

What is company cash figure?

Enretprise cash is 0.000.